Evaluation of Sitagliptin for the treatment of adult patients with type 2 diabetes mellitus: a systematic review of cost-effectiveness
Introduction: Type 2 diabetes mellitus is a global public health problem, being one of the main causes of mortality in Ecuador. Sitagliptin was the first locally marketed incretin-enhancing drug. Countries do not have unlimited resources to meet the health needs of their population, so they must ado...
Saved in:
主要作者: | |
---|---|
其他作者: | , , |
格式: | article |
语言: | spa |
出版: |
2020
|
主题: | |
在线阅读: | https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/2661 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|